Search Results - kwang+kim

2 Results Sort By:
C10349: Prevention and Treatment of Bacterial and Fungal Meningitis
C10349: Prevention and Treatment of Bacterial and Fungal MeningitisValue Proposition: Johns Hopkins University is currently seeking licensees for a method of preventing meningitis caused by bacterial or fungal infection. Meningitis is a serious and often deadly inflammation of the central nervous system. The most susceptible populations for fungal meningitis...
Published: 6/26/2025   |   Inventor(s): Kwang Kim
Keywords(s): Antagonists/Inhibitors, Disease Indication, Infectious Diseases, Meningitis, Non-novel, Predicted Novelty, Small Molecules, Therapeutic Matter, Therapeutic Substance, Therapeutics
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Infectious Diseases, Clinical and Disease Specializations > Inflammation, Clinical and Disease Specializations > Neurology > Meningitis, Technology Classifications > Therapeutic Modalities > Small Molecules, Clinical and Disease Specializations > Neurology, Technology Classifications > Therapeutic Modalities
C04942: Vaccine against E. Coli Bacteremia and sepsis
Value Proposition: E. coli is the most common gram-negative organism causing nosocomial bacteremia related infection in elderly patients. The mortality and morbidity associated with E. coli bacteremia is substantial. E. coli sepsis is associated with an estimated 40,000 deaths each year at a cost of two billion dollars in the US alone. JHU inventors...
Published: 6/26/2025   |   Inventor(s): Kwang Kim
Keywords(s): Bacteria, Bacterial Infections, Biologics, Disease Indication, E. Coli, Escherichia coli, Food Borne Diseases, Therapeutic Matter, Therapeutic Substance, Therapeutics, Vaccine
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Infectious Diseases > Bacterial Infections, Clinical and Disease Specializations > Infectious Diseases > Escherichia coli, Technology Classifications > Research Tools > Proteins, Ligands & Receptors, Technology Classifications > Therapeutic Modalities > Vaccines, Clinical and Disease Specializations > Infectious Diseases, Technology Classifications > Research Tools, Technology Classifications > Therapeutic Modalities
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum